Live feed08:00:00·268dPRReleasevia QuantisnowAbbVie Submits Biologics License Application (BLA) to U.S. FDA for Pivekimab sunirine (PVEK) - an Investigational Antibody-Drug Conjugate (ADC) to Treat Rare Cancer with Limited Treatment OptionsByQuantisnow·Wall Street's wire, on your screen.ABBV· AbbVie Inc.Health Care
